DAGLA antibody (Diacylglycerol Lipase, alpha) (Cy7)

Details for Product anti-DAGLA Antibody No. ABIN1411488, Supplier: Log in to see
Antigen
  • C11orf11
  • DAGL(ALPHA)
  • DAGLALPHA
  • NSDDR
  • Nsddr
  • diacylglycerol lipase alpha
  • diacylglycerol lipase, alpha
  • DAGLA
  • dagla
  • Dagla
Reactivity
Human, Mouse (Murine), Rat (Rattus)
57
30
19
Host
Rabbit
36
21
Clonality
Polyclonal
Conjugate
This DAGLA antibody is conjugated to Cy7
4
4
4
4
3
3
1
1
1
1
1
1
1
1
1
1
Application
Immunofluorescence (Paraffin-embedded Sections) (IF (p))
43
33
20
14
12
3
1
Options
Supplier
Log in to see
Supplier Product No.
Log in to see
Immunogen KLH conjugated synthetic peptide derived from human DAGLA
Isotype IgG
Purification Purified by Protein A.
Plasmids, Primers & others Plasmids, Primers & others DAGLA products on genomics-online (e.g. as negative or positive controls)
Antigen
Alternative Name Dagla (DAGLA Antibody Abstract)
Background

Catalyzes the hydrolysis of diacylglycerol (DAG) to 2-arachidonoyl-glycerol (2-AG), the most abundant endocannabinoid in tissues. Required for axonal growth during development and for retrograde synaptic signaling at mature synapses.

Subcellular location: Extracellular

Synonyms: Sn1-specific diacylglycerol lipase alpha, DGL-alpha, Neural stem cell-derived dendrite regulator, DAGLA, C11orf11, KIAA0659, NSDDR

Gene ID 747
Application Notes IF(IHC-P) 1:50-200
Restrictions For Research Use only
Format Liquid
Concentration 1 μg/μL
Buffer Aqueous buffered solution containing 1 % BSA, 50 % glycerol and 0.09 % sodium azide.
Preservative Sodium azide
Precaution of Use This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
Storage 4 °C
Storage Comment Store at 4°C
Expiry Date 12 months
Did you look for something else?